Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marta Osorio Rodríguez"'
Autor:
Miguel Angel Seguí-Palmer, Clara Ejarque, Sandra Soriano, Laia Vilà, Pablo Villace Gallego, Enrique Gallardo Diaz, Ismael Macias Declara, Paula Ribera Fernandez, Laura Medina, Teresa Bonfill, Julia Giner Joaquin, Pablo Andreu, Marta Osorio Rodríguez
Publikováno v:
Journal of Clinical Oncology. 39:e24020-e24020
e24020 Background: Elderly patients (pts) diagnosed with cancer may present frailty conditions at baseline that could have a direct impact on tolerance and toxicity of oncological treatments (ttm). Comprehensive geriatric assessment (CGA) is consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f7bde93531431e0387b579c685da698
https://doi.org/10.1200/jco.2021.39.15_suppl.e24020
https://doi.org/10.1200/jco.2021.39.15_suppl.e24020
Autor:
Ana de la Torre, Concepción del Castillo Carrillo, Marta Osorio Rodríguez, Mario Mendoza del Pino, Idania Bravo, Rolando Rives, Marta González Dueñas, Elia Neninger Vinageras, Carmen Viada, Agustín Lage Dávila, Gonzalez Marinello Gisela Maria, Soraida Acosta Brooks, Beatriz García Verdecia, Daniel Abreu Abreu, Mauricio Catala Ferrer, Tania Crombet Ramos
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(9)
Purpose We show the result of a randomized phase II clinical trial with an epidermal growth factor (EGF)-based cancer vaccine in advanced non–small-cell lung cancer (NSCLC) patients, evaluating immunogenicity, safety, and effect on survival. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75fda7d9df681ad43e530b79f885616f
https://pubmed.ncbi.nlm.nih.gov/18349390
https://pubmed.ncbi.nlm.nih.gov/18349390